Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients
about
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicityRole of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureusProtein binding and serum bactericidal activities of vancomycin and teicoplanin.Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditisPopulation pharmacokinetic study of teicoplanin in severely neutropenic patients.Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis.Antimicrobial susceptibilities of Erysipelothrix rhusiopathiaeTeicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance dosesTreatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin4-week treatment of streptococcal native valve endocarditis with high-dose teicoplaninFailure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.Teicoplanin in perspective. A critical comparison with vancomycin.Screening and treatment of infections caused by resistant enterococci.Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditisEfficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.Use of teicoplanin in community medicine.A closer look at vancomycin, teicoplanin, and antimicrobial resistance.Treatment failure with teicoplanin and response to oral antibiotic regimens.Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis.
P2860
Q28326763-50AD95FA-9288-43CE-AF57-A88A814BBB7EQ33750776-47BF6DC5-0FBB-41A0-940B-D6339D784AECQ33756241-4BED880F-1B76-4C46-802C-E40E9B119F77Q35117545-2E402302-BE4F-4E3E-B5A4-F472ACE29199Q35121434-26FFDDA1-3C63-4070-951C-C82E9A870C99Q35124463-A5A03542-4493-4699-85FC-77D55842E0A8Q35138989-57851007-B8AC-4DB5-B5E5-9773EB4AC4A9Q35251599-9F2370FE-4490-4FDB-A45E-A55234299377Q35279169-B089F80B-95DD-4100-AE5C-A17064EE3A0FQ35280642-200490CE-5DCA-45D0-9C98-C452A67ECC64Q35285763-E0941DB7-995F-4C7A-A3B3-83720122B941Q35845550-F2112AD4-5CE9-4561-A143-EFC8E3EECEAFQ36752580-0216B6CA-D7B7-4743-97FB-37C36FD18C3AQ36753066-5C06BC7E-D6C7-4F2E-8C0F-3D0BA4FBCF65Q36754480-61E7244B-2E41-4BEE-871B-17D28117BEBDQ37113420-FC811A24-2A39-4599-A193-A059B26DACABQ37711795-B28A2E6A-0F13-4375-BEDF-84439C6A14D7Q39477095-6C68265B-AD9F-4248-A720-0B032CA4552FQ39815914-83B4C291-E2B5-4D8F-87A0-B0A9C4B5E6D8Q40284247-97CC87D2-E5F5-4FEA-B1E6-8DC0CE531E3AQ40584161-54C2AE6C-AA93-4583-888E-9BC1A395646DQ41646436-19E60E78-64D1-412A-AD95-FC7113784B78Q43771971-1CE44F64-D700-4343-A6C9-7599189DFE1CQ54169300-CA53EB41-B256-4796-BF0F-4310FD61E561
P2860
Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Evaluation of teicoplanin for ...... -positive cocci in 20 patients
@ast
Evaluation of teicoplanin for ...... -positive cocci in 20 patients
@en
type
label
Evaluation of teicoplanin for ...... -positive cocci in 20 patients
@ast
Evaluation of teicoplanin for ...... -positive cocci in 20 patients
@en
prefLabel
Evaluation of teicoplanin for ...... -positive cocci in 20 patients
@ast
Evaluation of teicoplanin for ...... -positive cocci in 20 patients
@en
P2093
P2860
P356
P1476
Evaluation of teicoplanin for ...... -positive cocci in 20 patients
@en
P2093
Leclercq P
Perronne C
P2860
P304
P356
10.1128/AAC.33.6.871
P407
P577
1989-06-01T00:00:00Z